Interventional Spine launches new line of Opticage lumbar interbody fusion products


Interventional Spine has launched a new line of products, which were showcased at this year’s International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting in Las Vegas, USA.

The new products include recent size additions to the Opticage Lumbar Fusion line of spine products, as well as lordotic versions of the interbody device.

Joseph Darling, Interventional Spine’s chief operating officer, says that the new devices will, “build upon our existing line of products, [and] are designed to assist surgeons in delivering superior patient outcomes in an affordable manner for lumbar fusion surgery…this latest generation of the Opticage is derived from, and uses the same basic mechanism, as the original Opticage expandable which has been used in over 2,500 clinical cases.”

According to a press release, the new product features include the following:

Opticage G3

  • Improved expansion strength (1600N)
  • Support for multiple surgical approaches including PLIF, TLIF and lateral intraoperative flexibility
  • Significant graft window size
  • Lateral and TLIF designs for parallel and lordotic applications
  • OptiGraft inserter